• Flanders Investment & Trade
  • Team Vesalius

A professor of virology and clinical biology, Dr. Marc Van Ranst, started his professional career at the Albert Einstein College of Medicine in New York. 

Marc Van Ranst

KU Leuven

Oude Markt 13
3000 Leuven

He is affiliated with KU Leuven, one of Flanders’ five universities, where he heads the Clinical and Epidemiological Virology Laboratory. Van Ranst holds several board positions at different scientific institutions. Since 1995, he is also academically affiliated with the Faculty of Natural Sciences at Charles University in Prague, where he teaches bioinformatics.

He has published more than 270 articles in peer-reviewed journals and scientific books on molecular evolution and bioinformatics, and has won numerous international awards. Currently, Van Ranst plays a prominent role in the fight against the coronavirus.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?